References

1. Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail . 2017;19(5):595-602. doi: 10.1002/ejhf.779
2. Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant . 2015;34(12):1495-1504. doi: 10.1016/j.healun.2015.10.003
3. Hanke JS, Dogan G, Wert L, et al. Left ventricular assist device exchange for the treatment of HeartMate II pump thrombosis. J Thorac Dis . 2018;10(Suppl 15):S1728-S1736. doi: 10.21037/jtd.2018.01.115
4. Boyle AJ, Jorde UP, Sun B, et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol . 2014;63(9):880-888. doi: 10.1016/j.jacc.2013.08.1656
5. Kirklin JK, Cantor R, Mohacsi P, et al. First Annual IMACS Report: A global International Society for Heart and Lung Transplantation Registry for Mechanical Circulatory Support. J Heart Lung Transplant . 2016;35(4):407-412. doi: 10.1016/j.healun.2016.01.002
6. Mehra MR, Goldstein DJ, Uriel N, et al. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med . 2018;378(15):1386-1395. doi: 10.1056/NEJMoa1800866
7. Mehra MR, Naka Y, Uriel N, et al. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med . 2017;376(5):440-450. doi: 10.1056/NEJMoa1610426
8. Netuka I, Sood P, Pya Y, et al. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. J Am Coll Cardiol . 2015;66(23):2579-2589. doi: S0735-1097(15)06839-4
9. Krabatsch T, Netuka I, Schmitto JD, et al. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial. J Cardiothorac Surg . 2017;12(1):23-017. doi: 10.1186/s13019-017-0587-3
10. Gustafsson F, Shaw S, Lavee J, et al. Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry. Eur Heart J . 2018;39(37):3454-3460. doi: 10.1093/eurheartj/ehy513
11. Kormos RL, Antonides CFJ, Goldstein DJ, et al. Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium. The Journal of Heart and Lung Transplantation . 2020;39(8):735-750. doi: 10.1016/j.healun.2020.03.010
12. Mehra MR, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med . 2019;380(17):1618-1627. doi: 10.1056/NEJMoa1900486
13. Colombo PC, Mehra MR, Goldstein DJ, et al. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation . 2019;139(2):155-168. doi: 10.1161/CIRCULATIONAHA.118.037231
14. Uriel N, Colombo PC, Cleveland JC, et al. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation . 2017;135(21):2003-2012. doi: 10.1161/CIRCULATIONAHA.117.028303
15. Nassif ME, Tibrewala A, Raymer DS, et al. Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke. J Heart Lung Transplant . 2015;34(4):503-508. doi: S1053-2498(14)01414-4
16. Bansal A, Chan J, Bansal A, et al. Preoperative Vitamin K Reduces Blood Transfusions at Time of Left Ventricular Assist Device Implant. Ann Thorac Surg . 2019. doi: 10.1016/j.athoracsur.2019.06.101.
17. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol . 2010;105(7):1030-1035. doi: 10.1016/j.amjcard.2009.11.026
18. Meineri M, Van Rensburg AE, Vegas A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol . 2012;26(2):217-229. doi: 10.1016/j.bpa.2012.03.006
19. Lo C, Murphy D, Summerhayes R, et al. Right ventricular failure after implantation of continuous flow left ventricular assist device: analysis of predictors and outcomes. Clin Transplant . 2015;29(9):763-770. doi: 10.1111/ctr.12577
20. Bellavia D, Iacovoni A, Scardulla C, et al. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail . 2017;19(7):926-946. doi: 10.1002/ejhf.733
21. Raina A, Patarroyo-Aponte M. Prevention and Treatment of Right Ventricular Failure During Left Ventricular Assist Device Therapy. Crit Care Clin . 2018;34(3):439-452. doi: S0749-0704(18)30021-6
22. Ali HR, Kiernan MS, Choudhary G, et al. Right Ventricular Failure Post-Implantation of Left Ventricular Assist Device: Prevalence, Pathophysiology, and Predictors. ASAIO J . 2020;66(6):610-619. doi: 10.1097/MAT.0000000000001088
23. Ruiz-Cano MJ, Morshuis M, Koster A, et al. Risk factors of early right ventricular failure in patients undergoing LVAD implantation with intermediate Intermacs profile for advanced heart failure. J Card Surg . 2020;35(8):1832-1839. doi: 10.1111/jocs.14696